FDA potential problem drug list is just the tip of the iceberg

The news has been widely circulated regarding a new list of potential problem drugs, which has been published by the Food and Drug Administration.

What is not being widely addressed however, are the reasons for the list and what is (or is not) being done about the named pharmaceuticals which appear on it. The first potential problem drug list, which contains some names as familiar as insulin, Ivermectin and nitroglycerin, is a simple table of drug names and the "potential" problems which may be occurring with them.

Pharmaceutical industry pundits are quick to assert that the appearance of a drug's name on the list is not to be interpreted as indicating an actual problem with the drug or its use. They assert that the list merely names drugs which have generated reports of concern from hospitals, doctors, and patients.